The role of fluorine-18-fluorodeoxyglucose positron emission tomography in evaluating the response to tyrosine-kinase inhibitors in patients with metastatic primary renal cell carcinoma

Publicado en línea: 10 jul 2014

Páginas: 219 - 227

Recibido: 08 feb 2013

Aceptado: 21 ago 2013

DOI: https://doi.org/10.2478/raon-2013-0067

Palabras clave

fluorodeoxyglucose, positron emission tomography, advanced renal cell carcinoma, tyrosine-kinase inhibitors, response to treatment

© by Carmelo Caldarella

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.